Optune Lua creates tumor treating fields to disrupt cancer cell division, and it is used in conjunction with PD-1/PD-L1 ...

Novocure received a long-sought FDA approval for the use of its Tumor Treating Fields technology against metastatic non-small ...

Alongside immunotherapy or chemo, the wearable device helped patients live longer in a trial, though the results are somewhat controversial.

ROOT, Switzerland, October 01, 2024--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) will report financial results for the third quarter 2024 on Wednesday, October 30, 2024, before the U.S. financial ...

Shares of Novocure were trading higher in Tuesday's late session after the company said that the Food and Drug Administration had approved Optune Lua, its wearable treatment for certain types of lung ...

NovoCure's TTFields showed mixed clinical results in NSCLC, with minor overall survival improvement, questioning its broader adoption beyond glioblastoma. Financially, NovoCure remains strong with ...

Novocure Ltd (NASDAQ:NVCR) shares soared sharply after the announcement that the FDA had approved Optune Lua, a wearable ...

Novocure (NASDAQ: NVCR) will report financial results for the third quarter 2024 on Wednesday, October 30, 2024, before the U.S. financial markets open. Novocure management will host a conference ...

Successful expansion into these markets could substantially increase Novocure's patient base and revenue. The European market, with its diverse healthcare systems and large population, offers a vast ...

What is the best overall home security system? For total home coverage with an eye on important access points inside your house, nothing works as well as a complete security system, which includes ...

Close to 2000 South African Democratic Teachers’ Union (SADTU) delegates will converge at the Birchwood Hotel and Conference Centre in Boksburg, Ekurhuleni, for the union’s 10th National ...